TR200102221T2 - Kalp krizi sonrası tedavileri için moksonidin kullanımı - Google Patents
Kalp krizi sonrası tedavileri için moksonidin kullanımıInfo
- Publication number
- TR200102221T2 TR200102221T2 TR2001/02221T TR200102221T TR200102221T2 TR 200102221 T2 TR200102221 T2 TR 200102221T2 TR 2001/02221 T TR2001/02221 T TR 2001/02221T TR 200102221 T TR200102221 T TR 200102221T TR 200102221 T2 TR200102221 T2 TR 200102221T2
- Authority
- TR
- Turkey
- Prior art keywords
- moxonidine
- treatments
- heart attack
- infarction
- myocardic
- Prior art date
Links
- WPNJAUFVNXKLIM-UHFFFAOYSA-N Moxonidine Chemical compound COC1=NC(C)=NC(Cl)=C1NC1=NCCN1 WPNJAUFVNXKLIM-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003938 moxonidine Drugs 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 2
- 208000010125 myocardial infarction Diseases 0.000 title 1
- 206010061216 Infarction Diseases 0.000 abstract 3
- 230000007574 infarction Effects 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 230000006378 damage Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000002107 myocardial effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heat Treatment Of Articles (AREA)
- Details Of Spanners, Wrenches, And Screw Drivers And Accessories (AREA)
- Fire-Extinguishing Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Farming Of Fish And Shellfish (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Abstract
Miyokardin kalp enfarktüsüne bagli hasarlarinin tedavisi amaciyla moksonidinin ve fizyolojik açidan tolere edilebilen asit katki tuzlarinin, farmasötik preparatlarin üretimi tarif edilmektedir. Moksonidin ve fizyolojik açidan tolere edilebilen asit katki tuzlarini içeren farmasötik preparatlar miyokardik enfarktüs tedavisi ve/veya miyokardik enfarktüs sonrasi tedavi çerçevesinde kullanilmaya uygundurlar.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19903780 | 1999-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200102221T2 true TR200102221T2 (tr) | 2002-01-21 |
Family
ID=7895940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/02221T TR200102221T2 (tr) | 1999-02-01 | 2000-01-28 | Kalp krizi sonrası tedavileri için moksonidin kullanımı |
Country Status (26)
Country | Link |
---|---|
US (1) | US7041303B2 (tr) |
EP (1) | EP1150680B1 (tr) |
JP (1) | JP4686027B2 (tr) |
KR (1) | KR20010092793A (tr) |
CN (1) | CN1166363C (tr) |
AT (1) | ATE286731T1 (tr) |
AU (1) | AU774855B2 (tr) |
BR (1) | BR0007894A (tr) |
CA (1) | CA2361600C (tr) |
CZ (1) | CZ20012615A3 (tr) |
DE (2) | DE10003771A1 (tr) |
DK (1) | DK1150680T3 (tr) |
ES (1) | ES2235829T3 (tr) |
HK (1) | HK1042650B (tr) |
HU (1) | HUP0105210A3 (tr) |
IL (1) | IL144621A (tr) |
NO (1) | NO321061B1 (tr) |
NZ (1) | NZ513869A (tr) |
PL (1) | PL195124B1 (tr) |
PT (1) | PT1150680E (tr) |
RU (1) | RU2261097C2 (tr) |
SK (1) | SK10082001A3 (tr) |
TR (1) | TR200102221T2 (tr) |
UA (1) | UA67822C2 (tr) |
WO (1) | WO2000045820A1 (tr) |
ZA (1) | ZA200105827B (tr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102850331B (zh) * | 2012-09-17 | 2015-05-20 | 符爱清 | 一种化合物的制备方法 |
CN103483268B (zh) * | 2013-09-17 | 2015-10-14 | 常州大学 | 一种4,6-二氯-2-甲基-5-硝基嘧啶的制备方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3739779A1 (de) * | 1987-11-24 | 1989-06-08 | Beiersdorf Ag | Pharmazeutische praeparate |
BR9709546A (pt) * | 1996-06-06 | 1999-08-10 | Lilly Co Eli | Formulação e método para tratamento de insuficiéncia cardíaca digestiva |
-
2000
- 2000-01-28 CA CA002361600A patent/CA2361600C/en not_active Expired - Fee Related
- 2000-01-28 PL PL00350559A patent/PL195124B1/pl not_active IP Right Cessation
- 2000-01-28 UA UA2001075408A patent/UA67822C2/uk unknown
- 2000-01-28 WO PCT/EP2000/000655 patent/WO2000045820A1/de not_active Application Discontinuation
- 2000-01-28 JP JP2000596940A patent/JP4686027B2/ja not_active Expired - Fee Related
- 2000-01-28 CN CNB008032440A patent/CN1166363C/zh not_active Expired - Fee Related
- 2000-01-28 RU RU2001121019/14A patent/RU2261097C2/ru not_active IP Right Cessation
- 2000-01-28 SK SK1008-2001A patent/SK10082001A3/sk unknown
- 2000-01-28 CZ CZ20012615A patent/CZ20012615A3/cs unknown
- 2000-01-28 HU HU0105210A patent/HUP0105210A3/hu unknown
- 2000-01-28 KR KR1020017009232A patent/KR20010092793A/ko not_active Application Discontinuation
- 2000-01-28 TR TR2001/02221T patent/TR200102221T2/tr unknown
- 2000-01-28 AT AT00902638T patent/ATE286731T1/de not_active IP Right Cessation
- 2000-01-28 NZ NZ513869A patent/NZ513869A/xx unknown
- 2000-01-28 DE DE10003771A patent/DE10003771A1/de not_active Withdrawn
- 2000-01-28 IL IL14462100A patent/IL144621A/en not_active IP Right Cessation
- 2000-01-28 DE DE50009220T patent/DE50009220D1/de not_active Expired - Lifetime
- 2000-01-28 EP EP00902638A patent/EP1150680B1/de not_active Expired - Lifetime
- 2000-01-28 AU AU24404/00A patent/AU774855B2/en not_active Ceased
- 2000-01-28 PT PT00902638T patent/PT1150680E/pt unknown
- 2000-01-28 DK DK00902638T patent/DK1150680T3/da active
- 2000-01-28 ES ES00902638T patent/ES2235829T3/es not_active Expired - Lifetime
- 2000-01-28 BR BR0007894-8A patent/BR0007894A/pt not_active IP Right Cessation
-
2001
- 2001-07-16 ZA ZA200105827A patent/ZA200105827B/en unknown
- 2001-07-31 NO NO20013753A patent/NO321061B1/no unknown
- 2001-07-31 US US09/917,858 patent/US7041303B2/en not_active Expired - Fee Related
-
2002
- 2002-05-31 HK HK02104090.9A patent/HK1042650B/zh not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001012122A3 (en) | Method and system for treating cardiac arrest using hypothermia | |
AR016798A1 (es) | Uso de una cepa de lactobacillus para la elaboracion de un medicamento | |
IL195723A (en) | Use of p53 inhibitors for the preparation of medicament | |
CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
SE9900961D0 (sv) | Novel compounds | |
HUP9801924A2 (hu) | Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény | |
HUP9700806A2 (hu) | Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására | |
EE04330B1 (et) | Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks | |
TR200102221T2 (tr) | Kalp krizi sonrası tedavileri için moksonidin kullanımı | |
NO20020334L (no) | Anvendelse av tosylkloramid(er) for behandling av sykdommer på huden, slimhinner, organer og vev | |
NZ534221A (en) | A combination of a thrombolytic agent and levosimendan for the treatment of acute myocardial infarction | |
ES2192810T3 (es) | Empleo de monoxidina como medicamento de actividad estimulante de la termogenesis. | |
ATE345805T1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
EE200200549A (et) | Jagatud doosi teraapia veresooni kahjustava aktiivsusega | |
ZA988820B (en) | Use of delta-aminolaevulinic acid for the preparation of a topical medicament for the integral diagnosis and/or therapy of tumours in hollow organs | |
PT1305020E (pt) | Utilizacao de fibratos para a preparacao de um medicamento util no tratamento da insuficiencia cardiaca congestiva | |
RU99122488A (ru) | Способ лечения рака эндометрия | |
RU99104703A (ru) | Способ лечения травматического остеомиелита нижней челюсти | |
Lasagni et al. | Preliminary therapeutic results in onychomycosis with a special formulation | |
HUP0002905A2 (hu) | 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása | |
ES2148057A1 (es) | Nuevo uso del diacepam como potenciador del efecto de los inhibidores pde 3 | |
JPS59155318A (ja) | 細胞の活性剤とその活用方法 | |
TH43264A (th) | องค์ประกอบสำหรับการบำบัดรักษาแผลเรื้อรัง |